{
    "clinical_study": {
        "@rank": "166629", 
        "arm_group": [
            {
                "arm_group_label": "High Chloride", 
                "description": "Patients receiving .9% sodium choride for resuscitation"
            }, 
            {
                "arm_group_label": "Low chloride", 
                "description": "Patients receiving Plasmalyte for resuscitation"
            }
        ], 
        "brief_summary": {
            "textblock": "This observational study evaluates the impact of high and low chloride containing IV fluids\n      on administrative and clinical outcomes. The study uses a large electronic health dataset\n      and examines patients receiving fluid replacement and resuscitation. The hypothesis is that\n      high chloride solutions are associated with adverse outcomes as measured by administrative\n      data and by clinical parameters."
        }, 
        "brief_title": "Effects of IV Chloride Content on Outcomes", 
        "condition": [
            "SIRS", 
            "Balanced Fluids", 
            "Plasmalyte"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adults meeting SIRS criteria receiving at least 500 mL of fluid replacement on day of\n             SIRS.\n\n        Exclusion Criteria:\n\n          -  Receipt of starches or other colloids"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "adult patients with SIRS needing fluid replacement"
            }
        }, 
        "enrollment": {
            "#text": "3000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 5, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02083198", 
            "org_study_id": "Bax-BSP-HiLoCl"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "hyperchloremic acidosis", 
            "balanced fluids", 
            "plasmalyte"
        ], 
        "lastchanged_date": "March 10, 2014", 
        "location": {
            "contact": {
                "last_name": "Carol Schermer, MD"
            }, 
            "facility": {
                "address": {
                    "city": "Deerfield", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60015"
                }, 
                "name": "Baxter Healthcare"
            }, 
            "investigator": {
                "last_name": "Boston Strategic Partners", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "official_title": "A Comparison of High and Low Chloride Containing IV Fluid Solutions in Patients Undergoing Major Surgery and/or ICU Admission", 
        "other_outcome": {
            "measure": "readmission", 
            "safety_issue": "No", 
            "time_frame": "30, 60 and 90 day"
        }, 
        "overall_contact": {
            "email": "carol_schermer@baxter.com", 
            "last_name": "Carol Schermer, MD"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Inpatient mortality. Expected Length of inpatient stay is approximately 7 days", 
            "measure": "Mortality", 
            "safety_issue": "No", 
            "time_frame": "Hospitalization, Expected Length of inpatient stay is approximately 7 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02083198"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Length of Stay", 
                "safety_issue": "No", 
                "time_frame": "inpatient hospitalization, Expected Length of inpatient stay is approximately 7 days"
            }, 
            {
                "measure": "Acute renal failure", 
                "safety_issue": "No", 
                "time_frame": "inpatient hospitalization, Expected Length of inpatient stay is approximately 7 days"
            }, 
            {
                "measure": "Infections", 
                "safety_issue": "No", 
                "time_frame": "inpatient hospitalization, Expected Length of inpatient stay is approximately 7 days"
            }, 
            {
                "measure": "dysrhythmias", 
                "safety_issue": "No", 
                "time_frame": "inpatient hospitalization, Expected Length of inpatient stay is approximately 7 days"
            }, 
            {
                "measure": "Electrolyte disorders", 
                "safety_issue": "No", 
                "time_frame": "inpatient hospitalizationExpected Length of inpatient stay is approximately 7 days"
            }
        ], 
        "source": "Baxter Healthcare Corporation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Baxter Healthcare Corporation", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}